Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer

Gynecologic Oncology

Volumn 96, Issue 1, 2005, Pages 241-244

  Barranger, Emmanuel ^a   Kerrou, Khaldoun ^a   Petegnief, Yolande ^a   David Montefiore, Emmanuel ^a   Cortez, Annie ^a   Daraï, Emile ^a  

^a HÔPITAL TENON   (France)

Author keywords

Computed tomography; FDG; Intraoperative probe; Laparoscopy; Occult metastasis; Ovarian cancer; Positron emission tomography; Recurrence

Indexed keywords

CARBOPLATIN; FLUORODEOXYGLUCOSE; FUROSEMIDE; PACLITAXEL;

ADULT; ANAMNESIS; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; FEMALE; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; OVARY CANCER; PERITONEAL BIOPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR BIOPSY; VAGINAL HYSTERECTOMY;

COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LAPAROSCOPY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 10044280459     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.09.030     Document Type: Article

References (16)

1. R.T. Greenlee, M.B. Hill-Harmon, T. Murray, and M. Thun Cancer statistics, 2001 CA Cancer J. Clin. 51 2001 15 36
2. G.A. Omura, M.F. Brady, H.D. Homesley, E. Yordan, F.J. Major, and H.J. Buchsbaum Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the gynecologic oncology group experience J. Clin. Oncol. 9 1991 1138 1150
3. 18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma Eur. Radiol. 10 2000 761 767
4. J.M. Niloff, R.C. Bast Jr., E.M. Schaetzl, and R.C. Knapp Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer Am. J. Obstet. Gynecol. 151 1985 981 986
5. Y. Nakamoto, T. Saga, T. Ishimori, M. Mamede, K. Togashi, and T. Higuchi Clinical value of positron emission tomography with FDG for recurrent ovarian cancer Am. J. Roentgenol. 176 2001 1449 1454
6. R.E. Bristow, M.G. del Carmen, H.K. Pannu, C. Cohade, M.L. Zahurak, and E.K. Fishman Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT Gynecol. Oncol. 90 2003 519 528
7. T. Torizuka, S. Nobezawa, T. Kanno, M. Futatsubashi, E. Yoshikawa, and H. Okada Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-d-glucose Eur. J. Nucl. Med. 29 2002 797 803
8. C. Levenback, R.L. Coleman, T.W. Burke, W.M. Lin, W. Erdman, and M. Deavers Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy J. Clin. Oncol. 20 2002 688 693
9. E. Barranger, D. Grahek, A. Cortez, J.N. Talbot, S. Uzan, and E. Darai Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in patients with cervical carcinoma Cancer 97 2003 3003 3009
10. D.C. Desai, M. Arnold, S. Saha, G. Hinkle, D. Soble, and J. Fry Correlative whole-body FDG-PET and intraoperative gamma detection of FDG distribution in colorectal cancer Clin. Positron. Imaging 3 2000 189 196
11. E.E. Zervos, D.C. Desai, L.R. DePalatis, D. Soble, and E.W. Martin 18F-labeled fluorodeoxyglucose positron emission tomography-guided surgery for recurrent colorectal cancer: a feasibility study J. Surg. Res. 97 2001 9 13
12. R. Essner, E.C. Hsueh, P.I. Haigh, E.C. Glass, Y. Huynh, and F. Daghighian Application of an [18F]Fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy J. Surg. Res. 96 2001 120 126
13. L.E. Adam, J.S. Karp, M.E. Daube-Witherspoon, and R.J. Smith Performance of a whole-body PET scanner using curve-plate NaI(Tl) detectors J. Nucl. Med. 42 2001 1821 1830
14. S.C. Rubin, W.J. Hoskins, T.B. Hakes, B.S. Reichman, D. Chapman, and J.L. Lewis Jr. Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer Am. J. Obstet. Gynecol. 160 1989 667 671
15. H.K. Pannu, R.E. Bristow, C. Cohade, E.K. Fishman, and R.L. Wahl PET-CT in recurrent ovarian cancer: initial observations Radiographics 24 2004 209 223
16. S. Makhija, N. Howden, R. Edwards, J. Kelley, D.W. Townsend, and C.C. Meltzer Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review Gynecol. Oncol. 85 2002 53 58